Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 20
Healthy volunteers: yes

Brief summary:
The study is designed to evaluate elements of cognitive function in subjects receiving either fesoterodine or alprazolam.

Detailed description:
Evaluation of cognitive function

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: 4mg fesoterodine intervention 2: 8mg fesoterodine intervention 3: alprazolam 1mg intervention 4: Placebo
Intervention descriptions: intervention 1: 4mg tablet once daily for 6 days intervention 2: 4mg tablet once daily for 3 days followed by 8mg tablet once daily for 3 days intervention 3: 1mg tablet once on last day of treatment period at clinic intervention 4: Placebo tablet for fesoterodine once daily for 6 days and placebo tablet for alprazolam once on last day of treatment period at clinic

Protocol document: